Omeza, LLC (United States) has no DMF, CEP or site registration linked in our records. 9 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Omeza, LLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/omeza-llc

Overview

Omeza, LLC is a skin health company that develops a drug-device combination product called OCM™, designed to provide comprehensive therapy for all phases of wound healing.

Therapeutic areas

Wound CareDermatology

FDA compliance signals

9 FDA enforcement records linked to this company.

  • recall — Class II2024-02-14

    CGMP Deviations

  • recall — Class II2024-02-14

    CGMP Deviations

  • warning_letter2023-12-12

    FDA Warning Letter (drug product)

  • 4832023-07-28

    Complete instructions, procedures, specifications et. al.

  • 4832023-07-28

    Testing and release for distribution

  • 4832023-07-28

    Reports of Analysis (Components)

  • 4832023-07-28

    Sanitation--buildings not clean, free of infestation

  • 4832023-07-28

    Written program not followed

  • 4832023-07-28

    Written procedures not established/followed

For suppliers

Is this Omeza, LLC?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.